Product Name

Metronidazole

Name: Metronidazole - LGM Pharma
SKU: 443-48-1

CAS Number

443-48-1

LGM Pharma is an API distributor. LGM Pharma can supply CGMP and/or DMF products, subject to availability and manufacturer requirements. LGM Pharma does not sell or supply APIs or finished dosage products to individual patients, doctors, pharmacies, or any pharmaceutical companies.

Questions? Call our customer API support number 1-(800)-881-8210

Product Name:

Metronidazole

CAS Number:

443-48-1

Indication:

For the treatment of anaerobic infections and mixed infections, surgical prophylaxis requiring anaerobic coverage, Clostridium difficile-associated diarrhea and colitis, Helicobacter pylori infection and duodenal ulcer disease, bacterial vaginosis, Giardia lamblia gastro-enteritis, amebiasis caused by Entamoeba histolytica, acne rosacea (topical treatment), and Trichomonas infections.

Mode of Action:

Metronidazole is a prodrug. Unionized metronidazole is selective for anaerobic bacteria due to their ability to intracellularly reduce metronidazole to its active form. This reduced metronidazole then covalently binds to DNA, disrupt its helical structure, inhibiting bacterial nucleic acid synthesis and resulting in bacterial cell death.

Pharmacodynamics:

Metronidazole, a synthetic antibacterial and antiprotozoal agent of the nitroimidazole class, is used against protozoa such as Trichomonas vaginalis, amebiasis, and giardiasis. Metronidazole is extremely effective against anaerobic bacterial infections and is also used to treat Crohn's disease, antibiotic-associated diarrhea, and rosacea.

Metabolism:

Hepatic metabolism by hydroxylation, oxidation, and glucuronidation.

Toxicity:

LD50=500 mg/kg/day (orally in rat). Adverse effects include reversible peripheral neuropathy with prolonged therapy, CNS toxicity, disulfiram effect with alcohol, dark red-brown urine, metallic taste, nausea, epigastric distress, dizziness, vertigo and paresthesias associated with high doses, and neutropenia (reversible and mild).

IUPAC:

2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethan-1-ol

ATC:

A01AB17" D06BX01" G01AF01" J01XD01" P01AB01

PubChem:

4173

DrugBank:

DB00916 (APRD00631)

Formula:

C6H9N3O3

Molecular Mass:

171.154

Synonyms:

1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole, 1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole, 1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole, 1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole, 1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole, 2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole, 2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole, 2-Methyl-5-nitroimidazole-1-ethanol, 5-23-05-00063 (Beilstein Handbook Reference), Acromona, Anagiardil, Arilin, Atrivyl, Bayer 5360, Bexon, BRN 0611683, Caswell No. 579AA, CCRIS 410, Clont, CONT, Danizol, Deflamon, Deflamon-wirkstoff, Efloran, EINECS 207-136-1, Elyzol, Entizol, EPA Pesticide Chemical Code 120401, Eumin, Flagemona, Flagesol, Flagil, Flagyl, Flagyl ER, Flagyl I.V. rtu in plastic container, Fossyol, Giatricol, Gineflavir, HSDB 3129, Klion, Klont, Meronidal, Metro Gel, Metro I.V., Metro I.V. in plastic container, Metrocream, Metrogel, MetroGel-Vaginal, Metrolotion, Metromidol, Metronidaz, Metronidazol, Metronidazol [INN-Spanish], Metronidazole, Metronidazole in plastic container, Metronidazolo, Metronidazolo [DCIT], Metronidazolum, Metronidazolum [INN-Latin], Mexibol, Mexibol 'silanes', Monagyl, Monasin, Nalox, Neo-tric, NIDA, Noritate, Novonidazol, NSC 50364, NSC 69587, NSC-50364, Orvagil, Protostat, RP 8823, Sanatrichom, Satric, SC 10295, Takimetol, Trichazol, Trichex, Trichocide, Trichomol, Trichomonacid 'pharmachim', Trichopol, Tricocet, Tricom, Tricowas B, Trikacide, Trikamon, Trikojol, Trikozol, Trimeks, Trivazol, UNII-140QMO216E, Vagilen, Vagimid, Vandazole, Vertisal, Wagitran

SMILES:

CC1=NC=C(N1CCO)[N+]([O-])=O

AHFS Code:

84:04.92, 84:04.04, 08:30.92

InChi:

InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3

General Reference:

Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, Poston L: A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study. BJOG. 2006 Jan;113(1):65-74. Pubmed
Lamont RF: Can antibiotics prevent preterm birth—the pro and con debate. BJOG. 2005 Mar;112 Suppl 1:67-73. Pubmed
Williams CS, Woodcock KR: Do ethanol and metronidazole interact to produce a disulfiram-like reaction? Ann Pharmacother. 2000 Feb;34(2):255-7. Pubmed
Visapaa JP, Tillonen JS, Kaihovaara PS, Salaspuro MP: Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother. 2002 Jun;36(6):971-4. Pubmed

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

LGM currently offers Monoclonal Antibodies (mAbs) for non-GMP/R&D use. Please inquire about Monoclonal Antibodies produced under GMP conditions.

Questions? Call our customer API support number 1-(800)-881-8210.

Ask us about this product

API’s From Quality Manufacturers:

Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
Premium quality GMP certified and fully accredited API manufacturing plants
Technical packages as well as access to filed DMF, ASMF or CEP (subject to availability)
Regulatory and technical assistance towards any submission type based on specific customer requirements

Metronidazole

443-48-1

Ask us about this product

API’s From Quality Manufacturers:

Find an API Product